GENE ONLINE|News &
Opinion
Blog

brain cancer
News Flash Immunotherapy
Protein Suppression as Potential Pathway for Glioblastoma Immunotherapy
2025-03-18
Trials & Approvals FDA ApprovalBrain TumorFirst-in-class
Servier’s $1.8 Billion Acquisition Pays Off: FDA Approves First-In-Class Treatment for Two Types of Rare Brain Cancer
2024-08-07
R&D brain cancer
New Effective Biodegradable Solution for Brain Cancer
2023-06-19
Trials & Approvals brain cancer
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Trials & Approvals Orphan Drug Designation
Three Companies Received Orphan Drug Designations in One Day To Treat Rare Cancers
2022-06-20
LATEST
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
Seasonal Skin Irritations Rise, Driving Demand for Accessible and Easy-to-Use Treatments
2025-05-14
Tirzepatide Users See 20.2% Average Weight Loss in Obesity Management Trial
2025-05-14
iMMagine-1 Phase 2 Study Provides Data on Investigational Matter Characteristics and Behavior
2025-05-14
Novo Nordisk Partners with Septerna in $2.2 Billion Deal to Develop Oral Obesity Drugs
2025-05-14
SMA: Researchers Explore In Utero Treatment Methods to Mitigate Muscle Weakness Before Birth
2025-05-14
Emrelis Approved for Advanced NSCLC Patients with High c-Met Overexpression
2025-05-14
READ MORE
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top